China Digest: QureBio, Galaxy Future Technology in funding news

QureBio has raised about 200 million yuan ($31 million) in its Series B round of financing, while Galaxy Future Technology has secured $10 million in its angel and angel+ rounds.

QureBio nabs nearly $31m in Series B 

Biopharmaceutical firm QureBio has secured approximately 200 million yuan ($31 million) in its Series B round led by the affiliate industry fund of Bank of Communications’ BOCOM International.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter